APC - 2000
Potential Indication: Bronchospasm
Asthma is a chronic lung disease that inflames and narrows the airways. Asthma causes recurring periods of wheezing, chest tightness, shortness of breath, and coughing. Asthma affects people of all ages, but it most often starts during childhood. In the United States, more than 25 million people are known to have asthma and about 7 million of these people are children.
About the Taper DPI Technology Platform
As part of the acquisition agreement with 3M, Adamis has obtained worldwide rights to this Taper DPI platform technology in all indications in the dry powder inhalation field. The unique design uses proprietary 3M technology to store the active pharmaceutical ingredient (API) on a microstructured carrier tape. 3M will supply the drug delivery tape to Adamis under a separate supply agreement. In the future, Adamis intends to pursue other follow-on products using the Taper DPI patented technology platform with other formulations.